SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on June 15, 2021. The registrant is a Delaware corporation with principal executive offices in Westport, Connecticut, and its common stock trades on the NASDAQ Capital Market under the symbol BSGM. The filing serves as a Regulation FD disclosure regarding a corporate event.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
There are no material financial changes reported in this document. The sole material event disclosed is the Company's announcement that it will exhibit at the Heart Rhythm 2021 convention, scheduled for July 28-31, 2021, at the Boston Convention and Exhibition Center.
Guidance, Outlook, and Risks
The Company undertakes no obligation to update, supplement, or amend the materials attached to this filing. The information provided is not deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. No specific financial guidance, risk factors, or contingencies are detailed in this report.
Investor Verification Checklist
- Verify the dates and location of the Heart Rhythm 2021 convention (July 28-31, 2021, Boston, MA).
- Review the attached press release (Exhibit 99.1) for specific details on the Company's exhibition plans.
- Confirm that this filing does not constitute a formal financial update or forward-looking guidance.
- Check subsequent filings for any updates regarding the convention outcomes or financial impact.